Company / Current Assets per Share
Alaunos Therapeutics, Inc. Current Assets per Share History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.24
FY2025
5-year range
$0.25 / $1.72
FY2021-FY2025
Trend
-27.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has fluctuated over the past 10 years, ranging from $0.25 in FY2022 to $1.72 in FY2024.
Based on SEC 10-K filings.
1.24 in FY2025 with a 5-year CAGR of +11.6%.
Improved from $0.52 to $1.24 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +70.9%
- 5-Year CAGR
- +11.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share decreased 27.8% year-over-year.
- Peak current assets per share was recorded in FY2024.
- Lowest current assets per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.24 | -27.8% |
| FY2024 | $1.72 | +233.8% |
| FY2023 | $0.52 | +107.1% |
| FY2022 | $0.25 | -32.2% |
| FY2021 | $0.37 | -48.9% |
| FY2020 | $0.72 | +9.7% |
| FY2019 | $0.65 | +10.9% |
| FY2018 | $0.59 | -30.0% |
| FY2013 | $0.84 | -27.2% |
| FY2012 | $1.16 | -47.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026